Growing community of inventors

Sandy, UT, United States of America

Xiao-Hui Liu

Average Co-Inventor Count = 4.80

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 85

Xiao-Hui LiuHariprasad Vankayalapati (4 patents)Xiao-Hui LiuDavid J Bearss (4 patents)Xiao-Hui LiuYong Xu (2 patents)Xiao-Hui LiuPasit Phiasivongsa (2 patents)Xiao-Hui LiuSanjeev Redkar (2 patents)Xiao-Hui LiuRajashree Joshi-Hangal (2 patents)Xiao-Hui LiuXiao-Hui Liu (4 patents)Hariprasad VankayalapatiHariprasad Vankayalapati (50 patents)David J BearssDavid J Bearss (50 patents)Yong XuYong Xu (34 patents)Pasit PhiasivongsaPasit Phiasivongsa (26 patents)Sanjeev RedkarSanjeev Redkar (26 patents)Rajashree Joshi-HangalRajashree Joshi-Hangal (16 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Supergen, Inc (2 from 52 patents)

2. Tolero Pharmaceuticals, Inc. (1 from 21 patents)

3. Astex Pharmaceuticals, Inc. (1 from 11 patents)

4. Sumitomo Pharma Oncology, Inc. (11 patents)


4 patents:

1. 8710057 - Imidazo[1,2-B]pyridazine and pyrazolo[1 .5-A]pyrimidine derivatives and their use as protein kinase inhibitors

2. 8445502 - Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same

3. 7820684 - Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same

4. 7750007 - Imidazo[1,2-beta]pyridazine and pyrazolo[1,5-alpha]pyrimidine derivatives and their use as protein kinase inhibitors

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/7/2026
Loading…